(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one
Structure Info
- Chemspace ID
- CSSB00020618560 (In-Stock Building Blocks)
- CAS
- 529-55-5
- MFCD
- MFCD00210548, MFCD24369638
- IUPAC Name
- (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one
- Mol formula
- C21H22O10
- Mol weight
- 434 Da
- Catalog Number(s)
- 1160 S, 34034, 40432, 122441, 317007, 40432-0.05G, 40432-0.25G, 529-55-5, A591934, AA00DFMU, AC047484, ACM529555, ACQUIN167, AG00DFPM, AG26690, AKOS037515151, AR00DGEM, ArZ-UP486672, BBLS00020618560, BBP02208, BD143359, CD32001077, CFN98878, CSC020618560, EBC-618479, EC00DHVE, FN65941, HY-N1549, K33405, LN02183366, M24504, NP2002, P839040, ST00DH6E, TN2111, TX00DGVA, WLZ4742, Y5006323, ZX-CY008448, bbls00020618560
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 0.57
- Heavy atoms count
- 31
- Rotatable bond count
- 4
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.38
- Polar surface area (Å)
- 166
- Hydrogen bond acceptors count
- 10
- Hydrogen bond donors count
- 6
- Zoom the structure
- CSSB00020618560
Items Overall 98 items from 20 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 98 | 1 mg | 57.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 98 | 5 mg | 170.00 | |
| BLD Pharmatech Co., Limited (15% Off · Special Offer) | 1 day | United States To: | 98 | 10 mg | 254.00 | |
Description: Name:(S)-5-Hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one; Hazard statement: 9; CAS: 529-55-5 | ||||||
| BLD Pharmatech GmbH | 1 day | Germany To: | 98 | 1 mg | 57.00 | |
| BLD Pharmatech GmbH | 1 day | Germany To: | 98 | 5 mg | 170.00 | |
| BLD Pharmatech GmbH | 1 day | Germany To: | 98 | 10 mg | 254.00 | |
Description: Name:(S)-5-Hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one; Hazard statement: 9; CAS: 529-55-5 | ||||||
| Astatech CN | 2 days | China To: | 95 | 5 mg | 161.70 | |
| Astatech CN | 2 days | China To: | 95 | 25 mg | 546.70 | |
| Astatech CN | 2 days | China To: | 95 | 100 mg | 1,400.30 | |
Description: NARINGENIN 7-O-GLUCOSIDE; CAS: 529-55-5 | ||||||
| Astatech Inc | 2 days | United States To: | 95 | 5 mg | 161.70 | |
| Astatech Inc | 2 days | United States To: | 95 | 25 mg | 546.70 | |
| Astatech Inc | 2 days | United States To: | 95 | 100 mg | 1,400.30 | |
Description: NARINGENIN 7-O-GLUCOSIDE; CAS: 529-55-5 | ||||||
| 1st Scientific CN | 3 days | China To: | 98 | 1 mg | 46.20 | |
| 1st Scientific CN | 3 days | China To: | 98 | 5 mg | 137.50 | |
| 1st Scientific CN | 3 days | China To: | 98 | 10 mg | 204.60 | |
Description: Prunin; Hazard statement: 9; CAS: 529-55-5 | ||||||
| 1st Scientific LLC | 3 days | United States To: | 98 | 1 mg | 46.20 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 5 mg | 137.50 | |
| 1st Scientific LLC | 3 days | United States To: | 98 | 10 mg | 204.60 | |
Description: Prunin; Hazard statement: 9; CAS: 529-55-5 | ||||||
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 1 mg | 57.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 5 mg | 170.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 10 mg | 254.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 25 mg | 515.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 50 mg | 773.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 100 mg | 1,160.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 250 mg | 1,740.00 | |
| BLD PHARMATECH LTD CN | 7 days | China To: | 98 | 1 g | 2,610.00 | |
Description: Name:(S)-5-Hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one; Hazard statement: 9; CAS: 529-55-5 | ||||||
| AiFChem CN | 10 days | China To: | 98 | 1 mg | 53.00 | |
| AiFChem CN | 10 days | China To: | 98 | 5 mg | 157.00 | |
| AiFChem CN | 10 days | China To: | 98 | 10 mg | 235.00 | |
| AiFChem CN | 10 days | China To: | 98 | 25 mg | 476.00 | |
| AiFChem CN | 10 days | China To: | 98 | 50 mg | 713.00 | |
| AiFChem CN | 10 days | China To: | 98 | 100 mg | 1,070.00 | |
| AiFChem CN | 10 days | China To: | 98 | 250 mg | 1,605.00 | |
| AiFChem CN | 10 days | China To: | 98 | 1 g | 2,408.00 | |
Description: (S)-5-Hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one; Hazard statement: H302, H361, H372, H410; CAS: 529-55-5 | ||||||
| Angene International Limited | 10 days | China To: | 98 | 1 mg | 67.50 | |
| Angene International Limited | 10 days | China To: | 98 | 5 mg | 142.20 | |
| Angene International Limited | 10 days | China To: | 98 | 10 mg | 212.40 | |
| Angene International Limited | 10 days | China To: | 98 | 25 mg | 316.80 | |
| Angene International Limited | 10 days | China To: | 98 | 50 mg | 474.30 | |
| Angene International Limited | 10 days | China To: | 98 | 100 mg | 711.00 | |
| Angene International Limited | 10 days | China To: | 98 | 250 mg | 1,064.70 | |
Description: Prunin; CAS: 529-55-5 | ||||||
| Ambeed CN | 12 days | China To: | 98 | 1 mg | 51.30 | |
| Ambeed CN | 12 days | China To: | 98 | 5 mg | 153.00 | |
| Ambeed CN | 12 days | China To: | 98 | 10 mg | 228.60 | |
| Ambeed CN | 12 days | China To: | 98 | 25 mg | 463.50 | |
| Ambeed CN | 12 days | China To: | 98 | 50 mg | 695.70 | |
| Ambeed CN | 12 days | China To: | 98 | 100 mg | 1,044.00 | |
| Ambeed CN | 12 days | China To: | 98 | 250 mg | 1,566.00 | |
| Ambeed CN | 12 days | China To: | 98 | 1 g | 2,349.00 | |
Description: Name: Prunin; Hazard statement: 9; CAS: 529-55-5 | ||||||
| Ambeed GmbH | 12 days | Germany To: | 98 | 1 mg | 51.30 | |
| Ambeed GmbH | 12 days | Germany To: | 98 | 5 mg | 153.00 | |
| Ambeed GmbH | 12 days | Germany To: | 98 | 10 mg | 228.60 | |
Description: Name: Prunin; Hazard statement: 9; CAS: 529-55-5 | ||||||
| Ambeed, Inc. | 12 days | United States To: | 98 | 1 mg | 51.30 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 5 mg | 153.00 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 10 mg | 228.60 | |
| Ambeed, Inc. | 12 days | United States To: | 98 | 25 mg | 463.50 | |
Description: Name: Prunin; Hazard statement: 9; CAS: 529-55-5 | ||||||
| AA BLOCKS | 12 days | United States To: | 98 | 1 mg | 56.10 | |
| AA BLOCKS | 12 days | United States To: | 98 | 5 mg | 165.00 | |
| AA BLOCKS | 12 days | United States To: | 98 | 10 mg | 245.30 | |
| AA BLOCKS | 12 days | United States To: | 98 | 25 mg | 498.30 | |
Description: Prunin; CAS: 529-55-5 | ||||||
| BLD Pharmatech (India) Pvt Ltd | 12 days | India To: | 98 | 1 mg | 57.00 | |
| BLD Pharmatech (India) Pvt Ltd | 12 days | India To: | 98 | 5 mg | 170.00 | |
| BLD Pharmatech (India) Pvt Ltd | 12 days | India To: | 98 | 10 mg | 254.00 | |
Description: Name:(S)-5-Hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one; Hazard statement: 9; CAS: 529-55-5 | ||||||
| A2B Chem | 12 days | United States To: | 98 | 1 mg | 65.55 | |
| A2B Chem | 12 days | United States To: | 98 | 5 mg | 195.50 | |
| A2B Chem | 12 days | United States To: | 98 | 10 mg | 292.10 | |
| A2B Chem | 12 days | United States To: | 98 | 25 mg | 615.25 | |
Description: Prunin; CAS: 529-55-5 | ||||||
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 1 mg | 69.00 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 5 mg | 204.70 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 10 mg | 305.90 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 25 mg | 458.85 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 50 mg | 687.70 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 100 mg | 1,031.55 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 250 mg | 1,546.75 | |
| Aaron Chemicals LLC | 12 days | United States To: | 98 | 1 g | 4,966.85 | |
| BB4LS GS | 15 days | Latvia To: | 98 | 50 umol | 626.13 | |
| BB4LS GS | 15 days | Latvia To: | 98 | 100 umol | 957.00 | |
| BB4LS GS | 15 days | Latvia To: | 98 | 200 umol | 974.40 | |
| BB4LS GS | 15 days | Latvia To: | 98 | 300 umol | 1,487.70 | |
| BB4LS GS | 15 days | Latvia To: | 98 | 500 umol | 1,513.80 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 1 mg | 68.20 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 5 mg | 200.20 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 10 mg | 297.00 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 25 mg | 444.40 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 50 mg | 664.40 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 100 mg | 996.60 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 250 mg | 1,493.80 | |
| Accel Scientific, S.L. | 20 days | China To: | 98 | 1 g | 4,770.70 | |
Description: Prunin; Hazard statement: 9; CAS: 529-55-5 | ||||||
| eNovation CN | 20 days | China To: | 98 | 1 mg | 74.75 | |
| eNovation CN | 20 days | China To: | 98 | 5 mg | 143.75 | |
| eNovation CN | 20 days | China To: | 98 | 10 mg | 189.75 | |
| eNovation CN | 20 days | China To: | 98 | 25 mg | 368.00 | |
| eNovation CN | 20 days | China To: | 98 | 50 mg | 546.25 | |
Description: (S)-5-Hydroxy-2-(4-hydroxyphenyl)-7-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)chroman-4-one; CAS: 529-55-5 | ||||||
| 10X CHEM | TBD | United States To: | 98 | 1 mg | 46.20 | |
| 10X CHEM | TBD | United States To: | 98 | 5 mg | 137.50 | |
| 10X CHEM | TBD | United States To: | 98 | 10 mg | 205.70 | |
| 10X CHEM | TBD | United States To: | 98 | 25 mg | 490.60 | |
| 10X CHEM | TBD | United States To: | 98 | 100 mg | 1,841.40 | |
Description: Prunin; Hazard statement: 9; CAS: 529-55-5 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of (2S)-5-hydroxy-2-(4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB00159262107](/st/structure/200/2f76ad1f8ebb17c01c4854f73531bcb2/COC1%253DCC%253DC%2528C%253DC1%2529%255BC%2540%2540H%255D1CC%2528%253DO%2529C2%253DC%2528O%2529C%253DC%2528O%255BC%2540%2540H%255D3O%255BC%2540H%255D%2528CO%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D3O%2529C%253DC2O1.png)
![Chemical structure of (2S)-2-(3,4-dihydroxyphenyl)-5-hydroxy-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB00132312434](/st/structure/200/43dfd658f5bd80270a5d60d003b188c0/OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528OC2%253DCC%2528O%2529%253DC3C%2528%253DO%2529C%255BC%2540H%255D%2528OC3%253DC2%2529C2%253DCC%253DC%2528O%2529C%2528O%2529%253DC2%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of (2R,3R)-3,5-dihydroxy-2-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB00159260872](/st/structure/200/7a363fce9503e3f85e91978523bd9ea4/OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528OC2%253DCC%2528O%2529%253DC3C%2528%253DO%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D%2528OC3%253DC2%2529C2%253DCC%253DC%2528O%2529C%253DC2%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-{[(2S)-5-hydroxy-2-(4-hydroxyphenyl)-4-oxo-3,4-dihydro-2H-1-benzopyran-7-yl]oxy}oxane-2-carboxylic acid - CSSB00161152309](/st/structure/200/680438b2c253770c0dc8fd6228c19159/O%255BC%2540%2540H%255D1%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528OC2%253DCC%2528O%2529%253DC3C%2528%253DO%2529C%255BC%2540H%255D%2528OC3%253DC2%2529C2%253DCC%253DC%2528O%2529C%253DC2%2529O%255BC%2540%2540H%255D%2528%255BC%2540H%255D1O%2529C%2528O%2529%253DO.png)
![Chemical structure of (2S)-5-hydroxy-2-(4-hydroxyphenyl)-6,8-dimethyl-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB00137410618](/st/structure/200/fb713c0ca7d8230c69284a754ee8a204/CC1%253DC%2528O%2529C2%253DC%2528O%255BC%2540%2540H%255D%2528CC2%253DO%2529C2%253DCC%253DC%2528O%2529C%253DC2%2529C%2528C%2529%253DC1O%255BC%2540%2540H%255D1O%255BC%2540H%255D%2528CO%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D1O.png)
![Chemical structure of (2S)-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB00159261724](/st/structure/200/da6e4b0f0f7872cd8e0a3b6b6ba58c74/COC1%253DCC%253DC%2528C%253DC1O%2529%255BC%2540%2540H%255D1CC%2528%253DO%2529C2%253DC%2528O%2529C%253DC%2528O%255BC%2540%2540H%255D3O%255BC%2540H%255D%2528CO%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D3O%2529C%253DC2O1.png)
![Chemical structure of (2S)-5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB02515422302](/st/structure/200/cf3bcfa6ab835254956e2ff86a384b3e/COC1%253DCC%2528%253DCC%253DC1O%2529%255BC%2540%2540H%255D1CC%2528%253DO%2529C2%253DC%2528O%2529C%253DC%2528O%255BC%2540%2540H%255D3O%255BC%2540H%255D%2528CO%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D3O%2529C%253DC2O1.png)

![Chemical structure of 5-hydroxy-2-(4-hydroxyphenyl)-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB00159265866](/st/structure/200/55df27438a6e8c600c2ed5bcd947d4a1/OCC1OC%2528OC2%253DCC%2528O%2529%253DC3C%2528%253DO%2529CC%2528OC3%253DC2%2529C2%253DCC%253DC%2528O%2529C%253DC2%2529C%2528O%2529C%2528O%2529C1O.png)
![Chemical structure of (2R)-5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB00020627828](/st/structure/200/dc03e7c45008e6a9c498b80ee630376f/OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528OC2%253DCC%2528O%2529%253DC3C%2528%253DO%2529C%255BC%2540%2540H%255D%2528OC3%253DC2%2529C2%253DCC%253DC%2528O%2529C%253DC2%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of 5-hydroxy-2-(4-hydroxyphenyl)-7-{[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB02531768493](/st/structure/200/b699fe323553c95e279b49d5a943713b/OC%255BC%2540H%255D1OC%2528OC2%253DCC%2528O%2529%253DC3C%2528%253DO%2529CC%2528OC3%253DC2%2529C2%253DCC%253DC%2528O%2529C%253DC2%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of (2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-({[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB06744556268](/st/structure/200/cdf20dbbc870d7563ee53f9ebabfafac/OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528OC%255BC%2540H%255D2O%255BC%2540%2540H%255D%2528Oc3cc%2528O%2529c4C%2528%253DO%2529C%255BC%2540H%255D%2528Oc4c3%2529c3ccc%2528O%2529cc3%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D2O%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of (2S)-5-hydroxy-2-phenyl-7-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB00160522193](/st/structure/200/5de1cdbbee4f1341956d37ba0a053408/OC%255BC%2540H%255D1O%255BC%2540%2540H%255D%2528OC2%253DCC%2528O%2529%253DC3C%2528%253DO%2529C%255BC%2540H%255D%2528OC3%253DC2%2529C2%253DCC%253DCC%253DC2%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528O%2529%255BC%2540%2540H%255D1O.png)
![Chemical structure of 5-hydroxy-2-phenyl-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one - CSSB02515451861](/st/structure/200/6167f48dca57135027cd344718df4a1c/OCC1OC%2528OC2%253DCC%2528O%2529%253DC3C%2528%253DO%2529CC%2528OC3%253DC2%2529C2%253DCC%253DCC%253DC2%2529C%2528O%2529C%2528O%2529C1O.png)
![Chemical structure of (2S)-7-{[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-5-hydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one - CSSB00000053624](/st/structure/200/9cb98f373c3d2bb4b1e8d31bdb2e2c2f/C%255BC%2540%2540H%255D1O%255BC%2540%2540H%255D%2528O%255BC%2540%2540H%255D2%255BC%2540%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540%2540H%255D%2528CO%2529O%255BC%2540H%255D2OC2%253DCC%2528O%2529%253DC3C%2528%253DO%2529C%255BC%2540H%255D%2528OC3%253DC2%2529C2%253DCC%253DC%2528O%2529C%253DC2%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D%2528O%2529%255BC%2540H%255D1O.png)
